Tormere Analytics
OverviewStock ResearchChartsPortfolio LabOptions LabCalculatorsWatchlist
Data Explorer
Articles
Pricing
Privacy PolicyTerms of Service

ATHE

$3.32-1.48%website ↗⬇ financials (.py)

ALTERITY THERAPEUTICS LTD

Market Cap
—
Sector
Health Care
Industry
Biotechnology
Beta (raw)
0.23
60mo monthly vs SPY
P/E (TTM)
—
Price / TTM net income
P/S (TTM)
—
Price / TTM revenue
P/B
—
Price / stockholders equity
EV/EBITDA
—
TTM
Price Chart
Loading…

Signals

Insider Velocity
24.0x
buying
Congress
—
purchases / sales, 90d
Short Volume
27%
W/W -52.4pp

Market & Alt Data

News
15
recent articles
Activist
—
none in 180d
Analyst Consensus
Strong Buy
5 analysts
Velocity Score
23.98x
Avg Daily Buying (90d)
529 sh/day
Baseline Daily Buying
0.0 sh/day
Unique Buyers (90d)
1
Sort by
Type
Trade DateFiledOwnerRoleTypeSharesPriceValueOwned After
2026-08-312026-09-08Marks Peter AshleyDirectorPurchase47.6K$0.50$24K191.3KView

Reporting Insiders

  • Peter Ashley Marks
    Director
    1 transaction · last 2026-08-31

Recent News

European shares slip after three-day gain as rise in oil, yields weigh
Reuters · 2026-10-07
Alterity Therapeutics Presents New Analyses of ATH434 Phase 2 Data in Multiple System Atrophy at the 2026 International Congress of Parkinson’s Disease and Movement Disorders
Yahoo · 2026-10-05
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 2026-10-02
Director nominations close October 2 for Alterity Therapeutics (ATHE) shareholders.
Stock Titan · 2026-09-25
Alterity Therapeutics CEO speaks with Proactive at the ASX SMIDcaps Conference
Yahoo · 2026-09-23
[6-K] ALTERITY THERAPEUTICS LTD Current Report (Foreign Issuer)
Stock Titan · 2026-09-23
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 2026-09-16
Lake Street Initiates Coverage On Alterity Therapeutics with Buy Rating, Announces Price Target of $10
Benzinga · 2026-09-15
The German share price index DAX graph is pictured at the stock exchange in Frankfurt
The Daily News | Texas' Oldest Newspaper · 2026-09-08
Alterity Therapeutics to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2026
Yahoo Finance · 2026-09-03
German share price index DAX graph at the stock exchange in Frankfurt
The Daily News | Texas' Oldest Newspaper · 2026-08-15
Alterity Therapeutics Announces Granting of New U.S. Composition of Matter Patent for ATH434
Yahoo Finance · 2026-08-12
Alterity Therapeutics to Present at the 46th Annual Canaccord Genuity Growth Conference
Yahoo Finance · 2026-08-06
Europe's STOXX 600 closes at record high as earnings, tech gains lift sentiment
Reuters · 2026-08-04
Alterity Therapeutics Releases Appendix 4C – Q4 FY26 Quarterly Cash Flow Report & Corporate Update
Yahoo Finance · 2026-07-30

Informational purposes only, not investment advice.

ALTERITY THERAPEUTICS LTD (ATHE)

tormere.com/research/ATHE · generated 2026-10-07

$3.32
-1.48%
General Information
Price$3.32
Change-1.48%
Market Cap—
SectorHealth Care
IndustryBiotechnology
ExchangeNasdaq
Beta (raw, 60mo vs SPY)0.23
Signals
Insider Velocity24.0x buying
Congress Trades (90d)—
Short Volume
27% of daily vol
Conviction Score31/100
Analyst ConsensusSB 1 · B 3 · H 1 · S 0 · SS 0
Price Chart (1 Year)
2025-10-072026-10-07$5.89$2.92
Recent Insider Activity (Form 4) — Last 5
DateInsiderTypeSharesValue
2026-08-31Marks Peter AshleyP47,620$23,810
Recent News
  • European shares slip after three-day gain as rise in oil, yields weigh — Reuters · 2026-10-07
  • Alterity Therapeutics Presents New Analyses of ATH434 Phase 2 Data in Multiple System Atrophy at the 2026 International Congress of Parkinson’s Disease and Movement Disorders — Yahoo · 2026-10-05
  • 12 Health Care Stocks Moving In Friday's Pre-Market Session — Benzinga · 2026-10-02
  • Director nominations close October 2 for Alterity Therapeutics (ATHE) shareholders. — Stock Titan · 2026-09-25
  • Alterity Therapeutics CEO speaks with Proactive at the ASX SMIDcaps Conference — Yahoo · 2026-09-23

Tormere — informational purposes only, not investment advice.

Factor Profile

Pro
Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro →